| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 27,874 | 26,983 | 27,334 | 37,613 | | Cost of Revenue | 1,858 | 1,438 | 2,183 | 2,892 | | | Gross Profit | 26,016 | 25,545 | 25,151 | 34,721 | | | Operating Expenses | | Research Development | 16,727 | 15,713 | 17,837 | 17,174 | | Selling General and Administrative | 29,882 | 32,563 | 37,156 | 35,700 | | Non Recurring | 68 | (429) | (13,639) | (141) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (20,661) | (22,302) | (16,203) | (18,012) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 891 | 1,173 | 1,440 | 6,835 | | Earnings Before Interest And Taxes | (19,770) | (21,129) | (14,763) | (11,177) | | Interest Expense | 7,641 | 2,817 | 2,670 |
-
| | Income Before Tax | (27,411) | (23,946) | (17,433) | (11,177) | | Income Tax Expense | 85 | 25 | (7) | (496) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (27,496) | (23,971) | (17,426) | (10,681) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (27,496) | (23,971) | (17,426) | (10,681) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($27,496) | ($23,971) | ($17,426) | ($10,681) |
|
0.07% Nasdaq 
Income Statement
